Loading…
← CockpitCompetitor Analysis › 002584.SZ Xilong Scientific Co., Ltd. Class AOpen in the cockpit ↗

Xilong Scientific Co., Ltd. Class A002584.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum leader 86
Mkt cap
$716M
US dollars, full cap
Free float
100%
of shares outstanding
$/day
$38.1M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-2.5 pp
WACC 7.1%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥7.83
1D-1.0%
1W+5.7%
1M-1.1%
3M-3.7%
6M-4.5%
YTD-15.0%
1Y-6.1%
ATR %5.0%
52w lowhigh33.4% off high

What Xilong Scientific does

Employees: 1,420

Xilong Scientific at a glance

Size Xilong Scientific (002584.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $716M, the 2846th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥7.83 on 18 Nov 2026.

Performance Over six months the shares fell 4.5%, against -26.8% for the median peer and -20.0% for the China market (cap-weighted) — 4th highest of 21 in its peer set.

Growth Revenue grew 26.7% over the last twelve months (peer median +12.6%); the operating margin is 1.6% (peer median 4.0%).

Valuation It trades at 0.7× enterprise value to sales against a peer median of 1.5× (2nd cheapest of 21).

Capital Return on invested capital runs 2.5 points below its cost of capital (7.1% WACC).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026002584.SZ 95Peer median 75
Six months, rebased to 100: Xilong Scientific against the median of its 20 peers (local-currency closes).

Xilong Scientific financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥8.35BCN¥7.32BCN¥7.81BCN¥7.09BCN¥6.18B
Revenue growth—-6%+10%+15%—
Gross profitCN¥600MCN¥474MCN¥484MCN¥435MCN¥411M
EBITDAn/aCN¥212MCN¥209MCN¥166MCN¥132M
Net incomeCN¥49.2M-CN¥75.5MCN¥61.8MCN¥33.3MCN¥89.1M
Free cash flow-CN¥408M-CN¥38.6MCN¥249M-CN¥509M-CN¥515M
Capital expenditureCN¥273MCN¥100MCN¥44.9MCN¥215MCN¥324M
Total debtCN¥1.75BCN¥1.74BCN¥1.61BCN¥1.65BCN¥2.00B

Quarterly statements and history in the cockpit →

Xilong Scientific competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%0%301149301565603980GNFC093370000510000912002165EXPL3788WLKPNEO0008196002303010926882193008563005866030104220002584.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Xilong Scientific is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%1×2×3×301149301565603980GNFC093370000510000912002165EXPL3788WLKPNEO0008196002303010926882193008563005866030104220002584.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Xilong Scientific is the large dot.

Xilong Scientific competitors and peer comparison

How Xilong Scientific compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Xilong Scientific against its 20 peers (data as of 18 Nov 2026)
Measure002584.SZPeer medianRank in peer set
1-month return-1.1%-14.2%6th highest of 21
6-month return-4.5%-26.8%4th highest of 21
Distance from 52-week high-33.4%-48.0%5th highest of 21
Revenue growth (TTM)+26.7%+12.6%5th highest of 21
Operating margin1.6%4.0%8th lowest of 21
EV / Sales0.7×1.5×2nd cheapest of 21
ROIC minus cost of capital-2.5 pp-2.3 pp10th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Xilong Scientific 002584.SZChina$716M-5%+27%2%0.7×n/an/a
Shandong Longhua New Material 301149.SZChina$723M-44%+33%2%0.8×n/an/a
Sinolong New Materials 301565.SZChina$709M-34%+20%1%2.2×n/an/a
Zhejiang Jihua 603980.SSChina$735M+18%+17%4%1.7×6.9%-3.6%
Gujarat Narmada Valley Fertilizers & Chemicals GNFC.NSIndia$736M-14%+22%10%0.5×5.4%+7.2%
Foosung 093370.KSSouth Korea$697M-34%+41%11%1.8×n/an/a
Sichuan Xinjinlu 000510.SZChina$736M-44%-4%-15%3.2×n/an/a
Sichuan Lutianhua Company Limited By Shares 000912.SZChina$736M-27%-5%-4%1.2×n/an/a
Hongbaoli 002165.SZChina$695M-41%+10%-19%2.2×n/an/a
Societe Explosifs et Produits Chimiques EXPL.PAFrance$694M+8%+13%7%1.3×8.5%+9.8%
Hanking Gold International 3788.HKHong Kong$690M-26%-19%8%1.8×n/an/a
Westlake Chemical Partners LP WLKPUnited States$743M-6%+9%29%1.1×n/an/a
Neo Performance Materials NEO.TOCanada$746M-25%+36%16%1.2×n/an/a
Yueyang Xingchang Petro-Chemical 000819.SZChina$747M-22%+44%1%1.1×n/an/a
Hebei Cangzhou Dahua 600230.SSChina$687M-35%-1%4%1.0×-1.5%+22.6%
Zhejiang Zhengguang Industrial 301092.SZChina$758M-6%-5%13%7.4×n/an/a
Orinko Advanced Plastics 688219.SSChina$677M-31%+13%2%0.9×13.8%+9.5%
Nanjing COSMOS Chemical 300856.SZChina$758M-26%+12%12%3.0×3.6%+8.0%
Malion New Materials 300586.SZChina$675M-45%+4%-4%3.5×n/an/a
Zhejiang Wansheng 603010.SSChina$765M-41%+19%-26%1.7×n/an/a
Riken Technos 4220.TJapan$769M+48%+6%11%0.9×-4.3%+8.3%

Questions

Which companies are Xilong Scientific's closest peers?
The cockpit's peer set: Shandong Longhua New Material (301149.SZ), Sinolong New Materials (301565.SZ), Zhejiang Jihua (603980.SS), Gujarat Narmada Valley Fertilizers & Chemicals (GNFC.NS), Foosung (093370.KS), Sichuan Xinjinlu (000510.SZ), Sichuan Lutianhua Company Limited By Shares (000912.SZ), Hongbaoli (002165.SZ).
Is Xilong Scientific expensive compared with its peers?
On ev / sales it trades at 0.7× against a peer median of 1.5×, 2nd cheapest of 21 in its peer set.
How has Xilong Scientific stock performed?
Over six months to 18 Nov 2026 the shares returned -4.5% against -26.8% for the median peer; over one year -6.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.